GlassScriptPhysician profile
Kelly Scatton
NPI 1659089506
$2,915.13
in general payments reported to CMS, 2019-2025
20 companies · $752 in 2025
The $752 reported for 2025 was more than what 81% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $43.48 · 2023: $865 · 2024: $1,255 · 2025: $752.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,872.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,871.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $614.92 | 2023-2025 | Repatha, Tavneos |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $420.62 | 2023-2025 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $264.72 | 2023-2024 | Eliquis, Camzyos |
| Medtronic, INC. | $203.20 | 2022-2025 | Cobalt Dr Mri Surescan, Mycarelink |
| Scpharmaceuticals INC. | $153.72 | 2025 | |
| Janssen Pharmaceuticals, INC | $150.14 | 2023-2024 | Xarelto |
| Actelion Pharmaceuticals US, INC. | $132.30 | 2025 | Uptravi, Opsumit |
| Avadel Cns Pharmaceuticals, LLC | $125.00 | 2025 | Lumryz |
| Astrazeneca Pharmaceuticals LP | $123.26 | 2024 | Airsupra |
| Merck Sharp & Dohme LLC | $109.72 | 2023 | Verquvo |
| Dexcom, INC. | $106.64 | 2024 | Dexcom G6 Transmitter |
| Lilly USA, LLC | $99.18 | 2025 | Zepbound |
| Glaxosmithkline, LLC. | $88.04 | 2023 | Bexsero |
| Pfizer INC. | $79.02 | 2024 | |
| Mallinckrodt Hospital Products INC. | $78.98 | 2023 | Acthar |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $46.96 | 2024 | |
| Novo Nordisk INC | $38.43 | 2024 | Wegovy |
| Novartis Pharmaceuticals Corporation | $34.57 | 2024 | |
| Heartflow, INC. | $25.32 | 2023 | Ffrct |
| Lantheus Medical Imaging, INC. | $20.39 | 2023 | Definity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kelly Scatton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.